iBio Inc (IBIO)
2.67
+0.08
(+3.09%)
USD |
NYAM |
Nov 01, 16:00
2.71
+0.04
(+1.50%)
After-Hours: 20:00
iBio Enterprise Value: 9.837M for Nov. 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 9.837M |
| October 31, 2024 | 9.146M |
| October 30, 2024 | 10.53M |
| October 29, 2024 | 10.96M |
| October 28, 2024 | 11.56M |
| October 25, 2024 | 11.39M |
| October 24, 2024 | 10.96M |
| October 23, 2024 | 10.36M |
| October 22, 2024 | 11.74M |
| October 21, 2024 | 13.47M |
| October 18, 2024 | 11.56M |
| October 17, 2024 | 11.39M |
| October 16, 2024 | 11.39M |
| October 15, 2024 | 11.05M |
| October 14, 2024 | 9.232M |
| October 11, 2024 | 9.492M |
| October 10, 2024 | 9.405M |
| October 09, 2024 | 11.31M |
| October 08, 2024 | 9.664M |
| October 07, 2024 | 9.751M |
| October 04, 2024 | 5.691M |
| October 03, 2024 | 6.296M |
| October 02, 2024 | 6.036M |
| October 01, 2024 | 6.814M |
| September 30, 2024 | 5.950M |
| Date | Value |
|---|---|
| September 27, 2024 | 4.741M |
| September 26, 2024 | 3.618M |
| September 25, 2024 | 2.495M |
| September 24, 2024 | 2.581M |
| September 23, 2024 | 2.754M |
| September 20, 2024 | 3.791M |
| September 19, 2024 | 3.186M |
| September 18, 2024 | 2.210M |
| September 17, 2024 | 2.900M |
| September 16, 2024 | 3.332M |
| September 13, 2024 | 3.417M |
| September 12, 2024 | 3.176M |
| September 11, 2024 | 3.159M |
| September 10, 2024 | 2.383M |
| September 09, 2024 | 2.987M |
| September 06, 2024 | 2.124M |
| September 05, 2024 | 2.556M |
| September 04, 2024 | 2.642M |
| September 03, 2024 | 2.987M |
| August 30, 2024 | 3.763M |
| August 29, 2024 | 2.900M |
| August 28, 2024 | 3.332M |
| August 27, 2024 | 3.332M |
| August 26, 2024 | 3.866M |
| August 23, 2024 | 4.280M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
0.227M
Minimum
Aug 09 2024
843.20M
Maximum
Jul 20 2020
93.16M
Average
35.21M
Median
Mar 28 2023
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 3.615M |
| Palatin Technologies Inc | 13.93M |
| Theriva Biologics Inc | -12.69M |
| Oragenics Inc | 1.901M |
| Nanoviricides Inc | 16.04M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.778M |
| Revenue (Quarterly) | 0.175M |
| Total Expenses (Quarterly) | 3.584M |
| EPS Diluted (Quarterly) | -0.9019 |
| Profit Margin (Quarterly) | -4.44K% |
| Earnings Yield | -410.9% |
| Normalized Earnings Yield | -298.72 |